Superworth

Assembly Biosciences profit margin ASMB

Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.

Net margin, 12 months
−0.1%
Operating margin, 12 months
−11.8%
Peer median
11.6%

Over the twelve months to Jun 30, 2026, Assembly Biosciences kept −0.1% of its revenue as net profit, with an operating margin of −11.8%.

The median for 10 large drugmakers of a similar size is 11.6%.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025−8.5%−16.8%
FY2024n/an/a
FY2023n/an/a
FY2022n/an/a
FY2021n/an/a
FY2020−78.6%−81.9%
FY2019n/an/a
FY2018n/an/a
FY2017n/an/a
FY2016n/an/a
FY2015n/an/a
FY2014n/an/a
FY2013n/an/a
FY2012n/an/a
FY2011n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−0.1%n/a−11.8%
Q1 FY26−9.0%n/a−19.1%
Q4 FY25−8.5%n/a−16.8%
Q3 FY25n/an/an/a
Q2 FY25n/an/an/a
Q1 FY25n/an/an/a
Q4 FY24n/an/an/a
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Assembly Biosciences' size, closest first, today.

CompanyProfit margin
ASMBAssembly Biosciences−0.1%
ARVNArvinas2.9%
PBYIPuma Biotechnology11.6%
IRWDIronwood Pharmaceuticals33.4%
ZVRAZevra Therapeutics42.8%
CRMDCorMedix40.5%
COLLCollegium Pharmaceutical5.9%
NATRNatures Sunshine Products3.7%
ABUSArbutus Biopharma84.2%
AMPHAmphastar Pharmaceuticals10.8%
OMEROmerosn/m
Peer median11.6%

Where Assembly Biosciences ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Assembly Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.